Modular adeno-associated virus (rAAV) vectors used for cellular virus-directed enzyme prodrug therapy
Open Access
- 24 January 2014
- journal article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 4 (1), 3759
- https://doi.org/10.1038/srep03759
Abstract
The pre-clinical and clinical development of viral vehicles for gene transfer increased in recent years, and a recombinant adeno-associated virus (rAAV) drug took center stage upon approval in the European Union. However, lack of standardization, inefficient purification methods and complicated retargeting limit general usability. We address these obstacles by fusing rAAV-2 capsids with two modular targeting molecules (DARPin or Affibody) specific for a cancer cell-surface marker (EGFR) while simultaneously including an affinity tag (His-tag) in a surface-exposed loop. Equipping these particles with genes coding for prodrug converting enzymes (thymidine kinase or cytosine deaminase) we demonstrate tumor marker specific transduction and prodrug-dependent apoptosis of cancer cells. Coding terminal and loop modifications in one gene enabled specific and scalable purification. Our genetic parts for viral production adhere to a standardized cloning strategy facilitating rapid prototyping of virus directed enzyme prodrug therapy (VDEPT).Keywords
This publication has 53 references indexed in Scilit:
- Gene therapy clinical trials worldwide to 2012 – an updateThe Journal of Gene Medicine, 2013
- A view on EGFR-targeted therapies from the oncogene-addiction perspectiveFrontiers in Pharmacology, 2013
- Antitumor activity of mutant bacterial cytosine deaminase gene for colon cancerWorld Journal of Gastroenterology, 2011
- Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector AdministrationMolecular Therapy, 2010
- Fusion enzymes containing HSV-1 thymidine kinase mutants and guanylate kinase enhance prodrug sensitivity in vitro and in vivoCancer Gene Therapy, 2009
- Safety and Efficacy of Gene Transfer for Leber's Congenital AmaurosisThe New England Journal of Medicine, 2008
- Engineering BioBrick vectors from BioBrick partsJournal of Biological Engineering, 2008
- Surface-Exposed Adeno-Associated Virus Vp1-NLS Capsid Fusion Protein Rescues Infectivity of Noninfectious Wild-Type Vp2/Vp3 and Vp3-Only Capsids but Not That of Fivefold Pore Mutant VirionsJournal of Virology, 2007
- The state of the art of adeno-associated virus-based vectors in gene therapyVirology Journal, 2007
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004